News & Updates

Tocilizumab efficacy in RA not affected by comorbidities, obesity status

13 Oct 2020 by

Tocilizumab is a common treatment for rheumatoid arthritis (RA) patients with comorbid conditions or obesity and is effective irrespective of comorbidity burden or obesity status, according to a study.

Tocilizumab efficacy in RA not affected by comorbidities, obesity status

13 Oct 2020

Obesity detrimental in ankylosing spondylitis

08 Oct 2020

Obesity is tied to adverse outcomes in ankylosing spondylitis, including inflammation, disease activity, physical mobility, radiographic damage, health index, liver function, and cardiovascular risk factors, a study suggests.

Obesity detrimental in ankylosing spondylitis

08 Oct 2020

Admissions for acute myocardial infarction with rheumatoid arthritis on the rise

07 Oct 2020

While hospitalizations are on the rise for acute myocardial infarction (AMI) patients with rheumatoid arthritis, rates of in-hospital mortality seem to be decreasing, a new study has found.

Admissions for acute myocardial infarction with rheumatoid arthritis on the rise

07 Oct 2020

Lorecivivint for knee OA unsuccessful in phase IIa trial

05 Oct 2020

The novel Wnt pathway modulator lorecivivint does not appear to be effective for treating pain and inhibiting structural progression in moderate-to-severe knee osteoarthritis (OA), according to the results of a phase IIa trial.

Lorecivivint for knee OA unsuccessful in phase IIa trial

05 Oct 2020

Ritlecitinib for rheumatoid arthritis succeeds in phase II trial

02 Oct 2020

Ritlecitinib, an oral JAK3/TEC inhibitor, appears to be well tolerated and produce significant improvements disease activity in patients with rheumatoid arthritis, according to the results of a phase II study.

Ritlecitinib for rheumatoid arthritis succeeds in phase II trial

02 Oct 2020

$Bisphosphonates pose risk of atypical femur fracture$

Bisphosphonates pose risk of atypical femur fracture

30 Sep 2020

Bisphosphonates bear an increased hazard of developing atypical femur fracture, which rapidly decreases following treatment discontinuation, according to a study. This risk is more pronounced in Asians than in whites.

Bisphosphonates pose risk of atypical femur fracture

30 Sep 2020

Young age, osteomyelitis, pyogenic bacterial isolation predict sequelae in septic arthritis

28 Sep 2020 by

Young age, pyogenic bacterial isolation, and concomitant osteomyelitis are associated with a high risk of sequelae in septic arthritis (SA), according to a Singapore study.

Young age, osteomyelitis, pyogenic bacterial isolation predict sequelae in septic arthritis

28 Sep 2020

RA patients on low-dose glucocorticoids at greater risk of serious infection

28 Sep 2020

Long-term use of low-dose glucocorticoids results in a dose-dependent increase in the risk of serious infection in patients with rheumatoid arthritis (RA) on stable disease-modifying antirheumatic drug (DMARD) regimen, with small but significant risk even at doses of ≤5 mg/day, a study has shown.

RA patients on low-dose glucocorticoids at greater risk of serious infection

28 Sep 2020

Spinal manipulative treatments do not provide RELIEF for chronic low back pain

28 Sep 2020 by

Spinal manipulative therapies such as spinal manipulation and spinal mobilization did not seem effective for the management of mild-to-moderate chronic low back pain (LBP) in young adults, the RELIEF* trial has shown.

Spinal manipulative treatments do not provide RELIEF for chronic low back pain

28 Sep 2020

Pregabalin as monotherapy enough to manage fibromyalgia

26 Sep 2020

Pregabalin, used either alone or in combination with milnacipran, is effective in the treatment of patients with fibromyalgia, and combined therapy does not confer added benefits compared with monotherapy, according to a study.

Pregabalin as monotherapy enough to manage fibromyalgia

26 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Tocilizumab efficacy in RA not affected by comorbidities, obesity status

Tocilizumab efficacy in RA not affected by comorbidities, obesity status

Obesity detrimental in ankylosing spondylitis

Obesity detrimental in ankylosing spondylitis

Admissions for acute myocardial infarction with rheumatoid arthritis on the rise

Admissions for acute myocardial infarction with rheumatoid arthritis on the rise

Lorecivivint for knee OA unsuccessful in phase IIa trial

Lorecivivint for knee OA unsuccessful in phase IIa trial

Ritlecitinib for rheumatoid arthritis succeeds in phase II trial

Ritlecitinib for rheumatoid arthritis succeeds in phase II trial

Bisphosphonates pose risk of atypical femur fracture

Bisphosphonates pose risk of atypical femur fracture

Young age, osteomyelitis, pyogenic bacterial isolation predict sequelae in septic arthritis

Young age, osteomyelitis, pyogenic bacterial isolation predict sequelae in septic arthritis

RA patients on low-dose glucocorticoids at greater risk of serious infection

RA patients on low-dose glucocorticoids at greater risk of serious infection

Spinal manipulative treatments do not provide RELIEF for chronic low back pain

Spinal manipulative treatments do not provide RELIEF for chronic low back pain

Pregabalin as monotherapy enough to manage fibromyalgia

Pregabalin as monotherapy enough to manage fibromyalgia